CFDE Data Portal | Search NTM

	Label	Description
	NTM Gene (Entity type)	ENSG00000182667 - neurotrimin
	NTM associations Collection (Entity type)	Associations for NTM_associations
	NTM associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NTM-AS3 Gene (Entity type)	ENSG00000238117 - NTM antisense RNA 3
	ST002921 NTM Rawdata.zip File (Entity type)	A 24.8 GB file from Metabolomics produced from OBI:0003097 as part of the PR001815 project
	NTM-AS2 Gene (Entity type)	ENSG00000237654 - NTM antisense RNA 2
	GSE199107 tryptophan 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 4 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE101239 5 V 6 VALPROIC ACID MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

NTM

ENSG00000182667 - neurotrimin

NTM associations

Associations for NTM_associations

NTM associations.tsv

A file from IDG as part of the Harmonizome project

NTM-AS3

ENSG00000238117 - NTM antisense RNA 3

ST002921 NTM Rawdata.zip

A 24.8 GB file from Metabolomics produced from OBI:0003097 as part of the PR001815 project

NTM-AS2

ENSG00000237654 - NTM antisense RNA 2

GSE199107 tryptophan 6 v 7 human up

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human up

A Gene Set from LINCS

GSE48812 sulforaphane 4 v 10 human dn

A Gene Set from LINCS

GSE101239 5 V 6 VALPROIC ACID MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.